comparemela.com
Home
Live Updates
GLP-1R agonists clinical trial design must be improved to ease concerns : comparemela.com
GLP-1R agonists clinical trial design must be improved to ease concerns
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, have garnered a lot of attention in the pharma industry and beyond.
Related Keywords
Costanza Alciati
,
,
Bio Developments
,
Pipelines
,
Emerging Markets
,
Glp 1
,
Eli Lilly
,
Novo Nordisk
,
Obesity
,
Clinical Trial
,
comparemela.com © 2020. All Rights Reserved.